Obesity Drug Race Shifts Focus from Weight Loss to Long-Term Weight Management

Weight Loss Drug Market Could Reach $150 Billion Globally | Morgan Stanley The race to develop obesity drugs is entering a new phase. While the first goal was helping people lose weight, the focus is now shifting toward helping them keep the weight off safely and sustainably. New weight-loss medications known as GLP-1 drugs have … Read more

Eli Lilly’s New Weight-Loss Drug Retatrutide Shows Remarkable Results, Matching Surgery-Level Weight Loss

Eli Lilly’s Retatrutide Hits Record Weight Loss, Challenges Surgery Efficacy | Whalesbook A new experimental weight-loss drug from Eli Lilly is generating excitement after delivering some of the most impressive results ever seen in a clinical trial for obesity treatment. The drug, called retatrutide, helped participants lose up to 28.3% of their body weight over … Read more